Report me for selling fake medicine? Why are you crying when your illness relapses?

But if used in normal dosage,

Generally speaking, many problems can be found when patients undergo targeted examinations after taking medication for one year.

Even if you have only taken the medicine for half a year, these problems may be discovered, but they are very subtle and cannot be detected by general examinations. More professional examinations are needed to do so.

When Chen Xuan saw the simulation results, he suddenly understood.

Elshilan anti-cancer drugs can induce various sudden diseases, the mortality rate of these diseases is also very high, and it is difficult to rescue them in time.

For example, if the patient has such disease or is a high-risk patient,

Then, during the period of taking the anti-cancer drug Elshilan, it is more likely to be induced and the disease is more likely to suddenly occur, making it difficult to treat in time.

If you don't take medicine, the incidence rate may be only one in a thousand, but after taking medicine it may reach 10% or even 30%.

Therefore, deaths were discovered during the first two phases of clinical trials, but they were ultimately diagnosed as the cause of death caused by the patient's own disease, and it was not found to be induced by the Elshilan anti-cancer drug.

This is indeed very difficult to find out. Even Tencent did not find it at the beginning. They just kept analyzing it because they thought something was wrong.

If it weren't for the human hospital simulator, it would have been difficult for him to have evidence to prove a causal relationship between the two. The final result was the same as other inspection agencies, and he believed that there was no connection between the two.

It is because of the simulation of this machine that we can gradually see the problems and find the connection points.

In the first two phases of clinical trials, it was basically impossible to discover this problem because the dosage was too small and the duration of use was too short, so many signs could not be detected.

Of course, the initial deaths were all caused by patients who already had these diseases.

But this does not mean that only people with these diseases will be affected. The anti-cancer drug Elracetam can induce it in advance, but it does not mean that it will only induce it.

If it is just an induction, then this drug can specifically avoid these people in the future and put these high-risk patients on the banned list. Although half of the market is lost, it can still be put on the market normally.

After a large number of human body template simulations,

Chen Xuan discovered that even healthy people could still develop these diseases.

In other words, even people who would not otherwise suffer from these sudden illnesses may develop sudden illnesses due to long-term use of the anti-cancer drug Elshilan.

This period is generally between one and three years. After three years, it is the peak period of the disease, and it is also the main cause that directly leads to the 50% mortality rate.

If this drug is used to treat breast cancer, the mortality rate may be much higher than breast cancer itself.

Although many patients die from breast cancer every year, the mortality rate is not as shocking as 50%.

Moreover, this is the mortality rate after three years of taking the medicine. If you continue to take the medicine, the mortality rate will only get higher and higher.

"The Elshiran team should have discovered this problem."

"They probably discovered this problem during the Phase III clinical trial, but they were unwilling to let the project fail."

"Faced with Pfizer's massive acquisition, they are even less likely to pass up the chance to get rich quick. They may also be hoping for a lucky break, thinking the odds aren't that great."

Chen Xuan thought of this possibility.

Under normal circumstances, if such life-threatening adverse reactions are discovered, the clinical trial should be stopped immediately.

But when faced with hundreds of billions of dollars in profits, it is enough to make these people take risks and not give up so easily, especially before others discover the problem.